(TheNewswire)
Vancouver, BC / TheNewswire / January 16, 2018 -
INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to
reaffirm its increased target capacity to 76,000 kg based on expanding facilities in 2019 to approximately 520,000 square feet
outlined on January 16, 2018. Dan Kriznic, Invictus MD Chairman and CEO stated, “The Company has achieved a number of
important achievements, as we march towards fulfilling capacity goals during this historic and important year for
Canada’s cannabis industry. We started this company in 2014 with the intention of becoming Canada’s Cannabis Company.
With the granting of AB Laboratories Inc.’s sales license and the progress being made on the Phase 2 production facility at Acreage
Pharms Ltd.’s, key constructions milestones in the drive towards that intent are being achieved. This dramatically advances our
timeline for increasing our annual run-rate production capacity at our facilities to 26,000 kg in 2018 in time for the adult-use
market. Invictus MD’s current cash balance is approximately $32 million.
The Company also reports that it has granted 1,100,000 incentive stock options to directors and consultants of the
Company. The stock options are exercisable for a period of five years at an exercise price of $1.84 per share. The options
were granted under, and are subject to the terms and conditions of the Company's Stock Option Plan.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals within the Canadian cannabis sector, namely the
Licensed Producers under the ACMPR, being its 100% investment in Acreage Pharms Ltd., located in West-Central Alberta, and 33%
investment in AB Laboratories Inc., located near Hamilton, Ontario which has both its cultivation and sales license under ACMPR.
Combined the two licenses and an expected third license under AB Ventures have an approximate annual run-rate production capacity
of 76,000 kg by 2019. In addition to ACMPR licenses the Company has an 82.5% investment in Future Harvest Development Ltd. a
Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.
For more information, please visit www.invictus-md.com .
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
Cautionary Note Regarding Forward-Looking
Statements: This release includes certain statements and information that may constitute forward-looking information within the
meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private
Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the
potential production capacity of AB Labs, AB Ventures and Acreage Pharms’ production facilities, the granting of regulatory
approval and anticipated timing of AB Labs reaching full production capacity, the granting of a sales license under the ACMPR to AB
Ventures and Acreage Pharms, Acreage Pharms’ receipt of a sales license and the success and
timing of Acreage Pharms’ expansion plans, expected sales of inventory and the completion of the transaction contemplated by the
LOI and the resulting increase in the Company’s ownership interest in AB Labs are forward-looking statements and contain
forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking
terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events
or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and
analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the
assumptions that AB Labs, AB Ventures and Acreage Pharms will satisfy all conditions for, and receive, regulatory approval to sell
medical cannabis at their production facilities’ full capacity, AB Ventures will satisfy all conditions for and be granted a
license under the ACMPR, AB Ventures is able to successfully build a production facility, Acreage Pharms will satisfy all
conditions for and successfully obtain the anticipated sales license and will successfully complete its expansion plans, the
anticipated sales of inventory will take place on the terms and timing expected by management and all conditions to the transaction
contemplated by the LOI will be satisfied and the transaction will complete on the expected terms. These forward-looking statements
are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity,
performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking
statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation,
the risk that AB Labs, AB Ventures and Acreage Pharms will not receive regulatory approval to sell medical cannabis at their
production facilities for their full production capacity or at all, that AB Labs, AB Ventures or Acreage Pharms will not reach full
production capacity, that AB Ventures will not be granted a license under the ACMPR, that AB Ventures is not able to successfully
build a production facility, that Acreage Pharms is not able to obtain the anticipated sales license when expected by management or
at all or is not able to successfully complete its expansion plans, that the anticipated sales of inventory will not occur on the
terms and timing expected by management or at all and that the transaction contemplated by the LOI will not complete on the
expected terms or at all. Although management of the Company has attempted to identify important factors that could cause actual
results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will
prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are
cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial out-look that are incorporated by reference
herein, except in accordance with applicable securities laws. We seek safe harbor.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2018 TheNewswire - All rights reserved.